Deletions on the long arm of the Y chromosome are a well-known cause of male infertility and it is generally accepted that deletions involving the AZFb region are not compatible with sperm production. Here, we report on two patients for whom basic diagnostic tests showed a deletion of the AZFb region. Unexpectedly, both patients had some residual sperm production. Subsequently, extension and additional analyses of the AZFb region disclosed an aberrant deletion pattern. Therefore, these results emphasize the need for a detailed and powerful analysis of cases where first-line Yq deletion tests reveal an AZFb deletion. Moreover, our study clearly demonstrated that only a very careful selection of test markers will avoid the pitfall of a 'no further treatment possible' wrongful conclusion.
INTRODUCTION
Deletions on the long arm of the Y chromosome are associated to male infertility. These deletions occur in three regions: the AZFa, AZFb and AZFc regions, although deletions encompassing the AZFb+AZFc regions may also be found. The severity of the fertility problem is generally dependent on the type (i.e. location) of the deletion. Patients with a complete AZFa or AZFb deletion have no spermatozoa, also at the testicular level, while in about 50-70% of patients with an AZFc deletion a few spermatozoa can be observed either in the patients' ejaculate or in a testicular biopsy (Stouffs et al., 2005) .
In general, for around 7.5% of patients with azoospermia or severely reduced sperm concentration (<1 million spermatozoa/ mL) a Yq microdeletion can be detected. This frequency varies largely among different studies and can be explained mainly by the different inclusion or exclusion criteria for the patients to be analyzed. However, the diagnostic protocols can be quite different as well, and -especially in the first years after the introduction of AZF deletion analysis -a lot of false positive results have been published. This has encouraged the publication of guidelines for Yq microdeletion testing. The first EMQN (European Molecular Quality Network) guidelines were published in 2004 (Simoni et al., 2004) . For these guidelines, reliable markers were selected which are recommended for use in a routine diagnostic setting.
Recently, updated and detailed guidelines were endorsed by the EMQN for the analysis and interpretation of Yq microdeletions (Krausz et al., 2014) . These guidelines suggest a dual approach with a basic and an extension analysis. The basic analysis includes the use of markers sY84 and sY86 in the AZFa region, sY127 and sY134 in the AZFb region, and sY254 and sY255 in the AZFc region. Together with these AZF region markers, also an STS located in the SRY gene located on the short arm of the Y chromosome as well as a marker located in the ZFX and ZFY gene (located on both the X and the Y chromosome) are included. For all AZF deletions referred to as 'classic', both markers located in the AZF regions must always be deleted. When only one single marker is absent, an artifact must be suspected. When a deletion is observed, an extension analysis is suggested to better fine-tune the extent of the deletion. This extension analysis will also serve as an extra confirmation for the presence of the deletion. According to the EMQN guidelines, the extension analysis of the AZFb region should include STSs sY105 and sY121 or sY1224 at the proximal border, and sY143 or sY1192 and sY153 at the distal border (see Fig. 1 ). In case of an AZFb deletion, it is expected that markers sY105 and sY153 are present, while sY121, sY1224, sY143 and/ or sY1192 must be absent (Fig. 1) .
Here, we present two infertile men for whom the primary test show the absence of STS sY127 and sY134. However, the extension analysis showed an abnormal pattern. Furthermore, their non-classical AZFb deletions are compatible with sperm production although at severely reduced levels.
MATERIALS AND METHODS

Patients
Patients with azoospermia or severe oligozoospermia presenting at the Center for Reproductive Medicine and/or Center for Medical Genetics are routinely tested for the presence of Yq microdeletions and karyotype analysis according to the EAU guidelines (Jungwirth et al., 2012) .
Here, we present two patients with severe oligo-astheno-teratozoospermia and cryptozoospermia.
The first patient (patient 1) presented with infertility since 10 months. Investigations of the female partner were normal. The personal and familial history of the patient showed no remarkable events. Hormonal analyses were normal. Clinical examination and ultrasound of the scrotum revealed a normal volume of the testis on both sides and a varicocoele grade 4 at the left side.
The second patient (patient 2) presented with a primary infertility since 2 years based on a combination of a tubal and male factor. The history of the patient was uneventful. Clinical examination showed a testicular volume of 8 mL bilaterally. Hormonal profile was normal.
Both patients gave multiple ejaculates for diagnostic analysis and to cryopreserve semen in case of insufficient quantities of motile spermatozoa for ICSI available on the day of oocyte retrieval. Table 1 overviews these ejaculates according the WHO 2010 guidelines.
Patient 1 did not (yet) start any assisted reproductive treatment in our center.
Eventually patient 2 had four ICSI attempts after being counseled about the hereditary aspects of his Yq deletion. Motile spermatozoa (fresh) were always available for injection except for his second attempt. Although two ejaculates were asked on the day of the oocyte retrieval no spermatozoa were available in his ejaculate. Unfortunately he did not opted for the possibility to cryopreserve semen before this attempt and no frozen spermatozoa were available. Fine needle aspiration of the left testis was performed, but only 1 motile spermatozoa could be retrieved and no fertilization was obtained after injection. After the failed second ICSI attempt he gave multiple ejaculates to cryopreserve semen. However, in the third and fourth ICSI cycle sufficient numbers of motile spermatozoa were available in the fresh ejaculate on the day of oocyte retrieval. Good fertilization and adequate embryo quality was observed during his other three attempts. Frozen embryo transfer after the first fresh cycle resulted in a miscarriage. After his fourth attempt an ongoing pregnancy was obtained.
AZF analysis
The first-line Yq deletion testing was performed according to the guidelines provided by Simoni et al., (2004) and Krausz et al., (2014) .
The extension analysis for positive first-line analyses was also performed according the guidelines provided by Krausz et al., (2014) . Our analysis for AZFb deletions includes: sY105 and sY1224 at the proximal border and sY1192 and sY153 at the distal border. All four markers were tested in a multiplex PCR reaction.
Extra STS markers were applied in and around the AZFb region to further analyze/confirm the presence and extent of the deletion (see Results section for more details). The position of the markers is determined relative to each other according to the website: http://breakpointmapper.wi.mit.edu/mapper.html.
RESULTS
Routine genetic investigations for patients with severely reduced or absent sperm numbers (as in non-obstructive azoospermia) include karyotype analysis and the search for the presence of Yq microdeletions. For the latter, two multiplex PCR reactions were performed as described by Simoni et al., (2004) and Krausz et al., (2014) .
We found two patients in whom the primary test showed the absence of STS markers sY127 and sY134, indicating an AZFb deletion.
The extension analysis was performed using a home-made multiplex PCR reaction including markers sY105, sY1224, sY1192 and sY153 (Fig. 1) .
For the first patient, the extension analysis surprisingly showed that only sY1224 is missing, whereas sY1192 is present (Fig. 2, top of the figure) . For the second patient, extension analysis indicated that markers sY105 and sY1224 were absent, whereas markers sY1192 and sY153 were present (Fig. 3, top of  the figure) .
We then tested extra markers in or around the AZFb region with a multiplex PCR reaction previously described (Van Landuyt et al., 2000) . Only relevant markers are shown in Figs 2 and 3. AZFb sY127* sY134* sY1224* sY143 sY121 sY1192* sY153* sY105* Figure 1 Overview of STS markers advised in the EMQN guidelines and the markers used in the routine diagnostic setting of UZ Brussel (indicated with *). Please note that sY1224 OR sY121 and sY143 OR sY1192 (mutual exclusion) should be used. The black arrows should be present in case of a complete AZFb deletion, whereas the gray arrows are expected to be absent. For patient 1 marker sY117, located on at least two positions in the AZFb region of Yq was absent, as well as sY114. Marker sY143, more distally located in the AZFb region was also missing.
For patient 2, markers sY97 and sY102, located proximal of AZFb were absent, as well as sY114, sY117 and sY143 located in the AZFb region.
DISCUSSION
Deletions on the long arm of the AZFb region are known to be associated to testicular failure. It is generally accepted that -for patients with a 'complete' AZFb deletion -the chance to retrieve mature sperm cells either from the ejaculate or via testicular sperm extraction is nil (Jungwirth et al., 2012) .
In literature, one family and five individuals have been described with AZFb deletions that are compatible with sperm production (Rolf et al., 2002; Longepied et al., 2010; Plotton et al., 2010; Soares et al., 2012; Zhang et al., 2016) . Of these patients, only three would be classified as having a complete AZFb deletion when using the recommended basic set of primers (sY127 and sY134). The patient described by Longepied et al. (2010) was even having a AZFb + AZFc deletion. The remaining patient described by Soares et al. (2012) and the family (Rolf et al., 2002) undoubtedly have a partial AZFb deletion.
In this report, we describe two extra patients with residual sperm production in whom the basic routine genetic analysis would classify them as having a classical or complete AZFb deletion. One of the patients was even able to induce a pregnancy. Therefore, the presence of the deletion and the aberrant pattern was further investigated using extra STS markers in or around the AZFb region.
Remarkably, the extension analysis with markers sY105 and sY1224 at the proximal border and sY1192 and sY153 at the distal border, showed an atypical pattern. In the first patient, sY1192 was still present, indicating that the deletion could be smaller and consequently, an incomplete AZFb deletion might be present. Surprisingly, sY143 was absent. According to the EMQN guidelines, this marker can be used as an alternative for sY1192. Consequently, depending on the marker used, this deletion would be classified as complete or incomplete.
Also in the second patient, sY1192 is still present while sY143 is missing. Here, however, STS sY105 is also absent. Extra markers around sY105 are also missing, confirming that the deletion is exceeding the proximal border of the AZFb region. Of note, sY109 is present. As this marker is binding at least two positions (proximal and distal of AZFb), it is presumed that the region distal to AZFb is still present and at the origin of the amplification of this STS.
In the paper of Zhang et al., (2016) ; sY143 (and not sY1192) was used in the extension analysis. Therefore, it cannot be ruled out that the apparently classical AZFb deletion pattern described in this study is resembling the pattern described in the present paper. In the papers of Soares et al. (2012) , sY1192 is absent. Although sY143 was not used, it is predicted that this marker would also be missing. Also in the paper of Longepied et al. (2010) it is predicted that sY1192 and sY143 would be absent, although these markers were not used.
For both patients described in this study, the distal boundary of the deletion is located between markers sY143 and sY1192. The region in between spans~900 kb. Within this region, multiple protein coding transcripts are located, especially those belonging to the RBMY family (Fig. 4) . Furthermore, between sY1192 and the 'normal' distal boundary of the AZFb region (i.e. the proximal arm of palindrome P1), multiple gene transcripts are located. Among these genes are DAZ1 and DAZ2. Although both patients are suffering from severe oligozoospermia, the presence of the DAZ genes and extra transcripts of RBMY may still allow limited sperm production. AZFb sY127* sY134* sY1224* sY1192* sY153* sY105* sY102 sY97 sY109 sY109 sY117 sY114 sY117 sY143 Figure 2 Overview of markers present/absent in patient 1. Gray arrows are the markers that are absent. On top of the figure are the markers included in standard routine testing. Below are extra markers. Unfortunately none had a testicular biopsy for diagnostic purposes and consequently the testicular phenotype could not be determined.
The deletion detected in patient 1 is possibly caused by a recombination between palindromes P5 and P3. However, we cannot exclude that an extra inversion has occurred prior to the recombination event. For patient 2, the deletion is extending the proximal end of the AZFb region. Consequently, this deletion cannot be explained by a simple recombination event between palindromes. Extra studies are essential for determining the underlying mechanisms of the observed deletions.
In conclusion, we describe two oligozoospermic patients with a non-classical AZFb deletion. Our report stresses the need of performing the extension analysis whenever an AZFb deletion is detected. Solely through this extension analysis, aberrant patterns, that would be missed when only using the basic test with sY127 and sY134, can be detected. However, we have exposed a possible pitfall in the present marker selection. The current EMQN guidelines for testing AZF deletions are therefore in need of an amendment as markers sY143 and sY1192 (which are interchangeable according these guidelines) may give contradictory results. In our routine extension analysis, sY1192 was used to confirm the deletion at the distal border. Marker sY1192 is located on a unique position on the Y chromosome, between palindromes P2 and P3, which makes it a reliable marker. In both patients, this marker was still present. Yet, if we would have used sY143 instead, the aberrant pattern in patient 1 would have been missed. For patient 2, the conclusion would have been in favor of a larger AZFb deletion. Consequently, the use of both sY1192 and sY143 might be required for a reliable analysis. The presence/absence of sY1192 can be used as a decision-making marker: if sY1192 is still present, TESE might still be an option for the patient. However, at least two oligozoospermic men (presumably) lacking sY143 as well as sY1192 have been described indicating that at least two extra deletion patterns largely involving the AZFb region are compatible with sperm production.
More studies are essential to show the frequency of aberrant AZFb deletion patterns and its association with the presence or absence of sperm production.
